Syndax Pharmaceuticals (SNDX)
(Delayed Data from NSDQ)
$9.98 USD
+0.06 (0.60%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $9.98 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Fundamental Charts
About Market Cap
As of the previous market close, Syndax Pharmaceuticals, Inc. has a market cap of $853.59M, which represents its share price of $9.92 multiplied by its outstanding shares number of 86.05M. As a small-cap company, SNDX's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
SNDX 9.98 +0.06(0.60%)
Will SNDX be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SNDX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SNDX
All You Need to Know About Syndax (SNDX) Rating Upgrade to Buy
Earnings Preview: Jazz Pharmaceuticals (JAZZ) Q2 Earnings Expected to Decline
SNDX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Wall Street Analysts Predict a 237.83% Upside in Syndax (SNDX): Here's What You Should Know
Wall Street Analysts See a 219.98% Upside in Syndax (SNDX): Can the Stock Really Move This High?
Syndax Pharmaceuticals (SNDX) Reports Q1 Loss, Tops Revenue Estimates
Other News for SNDX
Syndax Pharmaceuticals (SNDX) Anticipates Q2 Earnings Announcement
Syndax Pharmaceuticals Q2 2025 Earnings Preview
Syndax Pharmaceuticals's Earnings: A Preview
Franklin Biotechnology Discovery Fund Q2 2025 Commentary
Syndax to Announce Second Quarter 2025 Financial Results and Host Conference Call and Webcast ...